TABLE 1.
Patient characteristics
| ICE group N = 175 | TEE group N = 49 | p | |
|---|---|---|---|
| Age, years | 76 ± 8 | 75 ± 7 | 0.622 |
| Sex (male) | 122 (70) | 35 (73) | 0.990 |
| Hypertension | 160 (91) | 46 (96) | 0.504 |
| Diabetes | 60 (34) | 10 (21) | 0.092 |
| CHA2DS2VASc score | 4.2 ± 1.38 | 4.5 ± 1.49 | 0.452 |
| HAS BLED score | 4.07 ± 0.99 | 3.93 ± 1.02 | 0.184 |
| Paroxysmal AF | 51 (29) | 11 (23) | 0.440 |
| Permanent AF | 122 (70) | 37 (77) | 0.558 |
| Prior stroke | 122 (70) | 31 (64) | 0.709 |
| Congestive heart failure | 30 (17) | 8 (17) | 0.633 |
| History of CAD | 51 (29) | 14 (28) | 0.999 |
| History of CABG | 10 (6) | 5 (10) | 0.516 |
| History of vascular disease | 37 (21) | 11 (23) | 0.836 |
| Prior TAVR | 3 (2) | 4 (8) | 0.076 |
| LVEF, % | 57 ± 7 | 57 ± 7 | 0.942 |
| Creatinine clearance, ml/min | 66 ± 23 | 61 ± 22 | 0.659 |
| NT‐proBNP pre, pg/ml | 3079 ± 11 567 | 1993 ± 2973 | 0.340 |
| NT‐proBNP post, pg/ml | 2491 ± 9006 | 2616 ± 3644 | 0.792 |
| Hs‐troponin post, pg/ml | 0.29 ± 0.33 | 0.40 ± 0.33 | 0.307 |
| Indication for LAAO | |||
| Previous bleeding under OAC | 161 (91) | 41 (84) | 0.778 |
| Cerebral amyloid angiopathy | 9 (5) | 3 (6) | |
| High risk of bleeding | 20 (11) | 3 (6) | |
| Stroke despite OAC | 5 (3) | 1 (2) |
Note: Data are presented as n (%), Mean ± SD.
Abbreviations: AF, atrial fibrillation; CABG, coronary artery bypass graft; CAD, coronary artery disease; ICE, Intracardiac echocardiography; LVEF, left ventricular ejection fraction; OAC, oral anticoagulant; TAVR, trans‐aortic valve replacement; TEE: trans‐esophageal echocardiography.